Wanbury is currently trading at Rs. 23.95, up by 0.45 points or 1.91 % from its previous closing of Rs. 23.50 on the BSE.
The scrip opened at Rs. 23.50 and has touched a high and low of Rs. 23.95 and Rs. 23.50 respectively. So far 455 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 37.80 on 17-Jan-2013 and a 52 week low of Rs. 15.65 on 06-Aug-2013.
Last one week high and low of the scrip stood at Rs. 24.95 and Rs. 23.00 respectively. The current market cap of the company is Rs. 46.93 crore.
The promoters holding in the company stood at 48.97 % while Institutions and Non-Institutions held 3.85 % and 44.34 % respectively.
Wanbury’s subsidiary - Cantabria Pharma S.L., Spain, has filed petition for voluntary insolvency in the Commercial Courts of Madrid, Spain on November 04, 2013.
Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.55 |
Dr. Reddys Lab | 1356.05 |
Cipla | 1464.90 |
Lupin | 2154.00 |
Zydus Lifesciences | 972.05 |
View more.. |